iSERA Lifesciences Share Price ₹151

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of iSERA Lifesciences

Quarter-by-quarter operating performance

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales +	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.19	1.16
Expenses +	0.02	0.01	0.02	0.01	0.07	0.01	0.01	0.07	0.04	0.02	0.00	0.47	0.59
Operating Profit	-0.02	-0.01	-0.02	-0.01	-0.07	-0.01	-0.01	-0.07	-0.04	-0.02	0.00	-0.28	0.57
OPM %												-147.37%	49.14%
Other Income +	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.27	0.00	0.01	0.00	0.06
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	-0.02	-0.01	-0.02	-0.01	-0.07	-0.01	-0.01	-0.07	0.23	-0.02	0.01	-0.28	0.63
Tax %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	12.70%
Net Profit +	-0.02	-0.01	-0.02	-0.01	-0.07	-0.01	-0.01	-0.07	0.23	-0.02	0.01	-0.28	0.55
EPS in Rs	-0.00	-0.00	-0.00	-0.00	-0.08	-0.01	-0.01	-0.08	0.27	-0.02	0.01	-0.33	0.65

Financials of iSERA Lifesciences

Annual income statement trend

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales +	10.90	25.50	21.36	28.92	12.30	2.13	2.13	0.00	0.00	0.00	0.00	1.36
Expenses +	10.28	25.14	20.92	28.46	11.98	2.19	0.19	0.11	0.11	0.09	0.13	1.09
Operating Profit	0.62	0.36	0.44	0.46	0.32	-0.06	1.94	-0.11	-0.11	-0.09	-0.13	0.27
OPM %	5.69%	1.41%	2.06%	1.59%	2.60%	-2.82%	91.08%					19.85%
Other Income +	0.00	-12.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.27	0.07
Interest	0.00	0.16	0.20	0.27	0.23	0.22	0.02	0.00	0.00	0.00	0.00	0.00
Depreciation	0.50	0.08	0.21	0.15	0.08	0.12	0.12	0.00	0.00	0.00	0.00	0.00
Profit before tax	0.12	-12.49	0.03	0.04	0.01	-0.40	1.80	-0.11	-0.11	-0.09	0.14	0.34
Tax %	0.00%	0.40%	100.00%	25.00%	200.00%	5.00%	1.11%	0.00%	0.00%	0.00%	0.00%	23.53%
Net Profit +	0.12	-12.54	0.00	0.04	-0.02	-0.42	1.78	-0.11	-0.11	-0.09	0.14	0.26
EPS in Rs	0.00	-0.46	0.00	0.00	-0.00	-0.02	0.06	-0.00	-0.00	-0.11	0.17	0.31
Dividend Payout %	0.00%	0.00%		0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials of iSERA Lifesciences

Capital structure and asset base

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	10.60	10.60	10.60	10.60	10.60	10.60	10.60	0.30	0.30	0.32	0.32	8.41
Reserves	2.44	-10.10	-10.09	-10.05	-10.07	-10.49	-10.71	-0.31	-0.42	-0.54	-0.42	-0.16
Borrowings +	4.97	6.15	6.83	7.49	7.53	6.56	2.02	0.00	0.13	0.18	1.61	1.66
Other Liabilities +	2.54	4.61	5.57	8.19	4.12	3.81	2.59	0.02	0.04	0.10	0.05	0.65
Total Liabilities	20.55	11.26	12.91	16.23	12.18	10.48	4.50	0.01	0.05	0.06	1.56	10.56
Fixed Assets +	6.65	0.48	0.44	0.45	0.75	0.62	0.43	0.00	0.00	0.00	0.00	0.00
CWIP	1.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	4.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets +	7.74	10.78	12.47	15.78	11.43	9.86	4.07	0.01	0.05	0.06	1.56	10.56
Total Assets	20.55	11.26	12.91	16.23	12.18	10.48	4.50	0.01	0.05	0.06	1.56	10.56

Financials of iSERA Lifesciences

Operating, investing and financing cash movement

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity +	0.50	0.81	-0.63	-0.51	0.34	0.97	4.45	-0.30	-0.12	-0.06	-1.40	-5.35
Cash from Investing Activity +	-1.16	-0.40	-0.16	-0.16	-0.38	0.00	0.10	0.00	0.00	0.00	0.00	0.06
Cash from Financing Activity +	0.69	-0.42	0.77	0.66	0.04	-0.97	-4.55	0.30	0.13	0.06	1.42	8.14
Net Cash Flow	0.04	-0.01	-0.02	-0.01	0.00	0.00	-0.01	0.00	0.00	0.00	0.02	2.85
Free Cash Flow	-0.78	0.41	-0.79	-0.67	-0.04	0.97	4.55	-0.30	-0.12	-0.06	-1.40	-5.35
CFO/OP	81%	225%	-143%	-109%	112%	-1,650%	229%	273%	109%	67%	1,062%	-1,952%

Financials of iSERA Lifesciences

Working capital efficiency and return ratios

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2025	Mar 2026
Debtor Days	192.55	122.81	174.64	177.96	297.34	1,470.28	498.66			322.06
Inventory Days			0.00	0.00	0.00	0.00
Days Payable
Cash Conversion Cycle	192.55	122.81	174.64	177.96	297.34	1,470.28	498.66			322.06
Working Capital Days	174.46	65.13	91.59	73.58	170.33	1,041.88	260.47			214.71
ROCE %	0.68%	2.27%	3.29%	4.03%	2.98%	-2.44%	42.42%	-11.58%	19.05%	5.95%

Happiest Minds Technologies Ltd (Q1 FY27)
Geographic balance (38% Americas, 31% Europe, 31% rest of world) and sector diversification support stable growth (Page 11). Key concall takeaways from…
Sonata Software Ltd (Q1 FY27)
AI order book contributes 18.2% to the overall order book. Key concall takeaways from Sonata Software Ltd's Q1 FY27 earnings call — and how it ranks against…
XT Global Infotech Ltd (Q1 FY27)
Consolidated revenue grew modestly by 1.1% YoY; management indicates real growth driven by a shift from onsite to higher-margin offshore delivery. Key concall…
InfoBeans Technologies Ltd (Q1 FY27)
The company serves large enterprise clients with a high retention rate (94%), providing a stable revenue base and opportunity for expansion within existing…

iSERA Lifesciences Share Price & Earnings Call Analysis